NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
NovaBridge Biosciences (NBP) appointed Dr. Srishti Gupta as Chief Executive Officer and a member of the Board of Directors, effective July 1, 2026. Outgoing CEO Xi-Yong (Sean) Fu will step down to pursue other opportunities but will support the company in an advisory capacity during the transition. Dr.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.